Surface advertising only. Internal a lot of problems. Even their interviews are low standard, main problem many patients went to other aesthetic clinic, and complain Dr Chong quality, rather burn their left over package than going back. This is so bad
Jimmy7890 is from another aesthetic clinic which is not recognized by the Malaysia Book of Records ? 🤔 Why so jealous of DC healthcare getting interviewed?
Just after 1 year the market share price felt below IPO price.. also the technical chart stick all negative shown STRONG SELLLLLLLLLL... All in just 1 yearrrrrrr...
Dow member McDonald’s closed more than 5% lower. The Centers for Disease Control and Prevention said late Tuesday that an E. coli outbreak tied to the fast-food giant’s Quarter Pounder burgers has resulted in 10 hospitalizations and one death.
DC Healthcare Holdings Berhad, has been actively expanding its operations by opening new branches across Malaysia. Their aggressive growth strategy has led to increased administrative and advertising expenses, contributing to recent financial losses. For instance, in the fourth quarter ended December 31, 2023, the company reported a net loss of RM1.07 million, despite achieving a revenue of RM17.57 million.
The share price has experienced a significant decline, closing at RM0.16 on November 8, 2024, marking a 69.23% drop over the past year. This downturn can be attributed to the financial losses and market concerns regarding the sustainability of its rapid expansion.
But I think the company's strategic initiatives, such as the establishment of new clinics in key locations like Johor Bahru and Ipoh, aim to tap into high-income markets and drive future revenue growth. Additionally, the implementation of an Employee Share Option Scheme (ESOS) is intended to align employee interests with company performance, potentially enhancing operational efficiency and profitability.
And I think, the share price may remain under pressure in the short term due to ongoing financial challenges and market scepticism. However, if the company's expansion efforts lead to increased market share and profitability, and if the ESOS successfully motivates employees to drive performance, there is potential for share price recovery in the medium to long term.
I think this will rebound sooner than later by 2nd Quarter 2025
Since its listing on Bursa, DCHCARE has encountered considerable financial challenges, reporting a net loss of RM18.49 million over the past twelve months and maintaining a negative profit margin of 32.82%. The stock has exhibited marked volatility, with weekly fluctuations averaging 10%, placing it among the top 25% of the most volatile stocks on the Malaysian market.
I believe the company’s strategy to expand its aesthetic services footprint—from 12 outlets in Q2 2023 to 17 in Q2 2024—alongside the launch of new product lines under the Ten Doctors brand and four additional outlets dedicated to slimming services, shows a strong commitment to growth. This increase, bringing the total to 21 outlets in Q2 2024 compared to the previous year’s 12, could create favourable prospects for financial recovery. However, the success of these initiatives will likely depend on broader market conditions and prevailing investor sentiment.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
ATmexys02
48 posts
Posted by ATmexys02 > 2 months ago | Report Abuse
No show left? Ride the nxt rebound wave?